Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 4.4B | 4.3B | 4.1B |
Cost of revenue | -889.4M | 1.1B | 1.1B | 1.1B |
Gross profit | 3.2B | 3.3B | 3.1B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.3B | 3.3B | 3.1B | 3.0B |
Operating income | -102.3M | 30M | -5.2M | 7.1M |
Non operating interest income | ||||
Income | 161.5M | 29.9M | 26.8M | 23M |
Expense | 50.5M | 52.6M | 53.5M | 74.7M |
Other income expense | — | — | — | — |
Pretax income | 99.7M | 7.7M | -27.3M | -41.2M |
Tax provision | -32.4M | 1.3M | -14.3M | -19.5M |
Net income | 147.9M | 6.4M | -13M | -21.7M |
Basic EPS | — | 0.0 | 0.0 | -0.1 |
Diluted EPS | — | 0.0 | 0.0 | -0.1 |
Basic average shares | — | 147.1M | 147.0M | 125M |
Diluted average shares | — | 147.1M | 147.0M | 125M |
EBITDA | 114.8M | 60.3M | 26.2M | 33.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | 16M | 14.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |